To advance scientific progress with any cell type, a basic level of knowledge needs to be acquired, including protocols for cell isolation, growth, expansion, differentiation, and more. It requires that characteristics of the cells be observed to determine how they are affected by environmental variation. To date, a significant amount has been learned about mesenchymal stem cells, as 30,697 scientific articles have been published about the cell type.[1] Of those, more than half (17,998) have been published within the last five years.[2] [Read more…]
Do You Know What Regions are Doing the Most Searches for Mesenchymal Stem Cells (MSCs)?
Google Trends is a supplemental service of Google Incorporated that analyzes trend data collected through Google Search.
It shows how often a particular search term is entered relative to total search-volume across various regions of the world and in various languages.
It is an absolutely incredible market research tool for assessing stem cell market dynamics, because it reflects real-time social behavior related to specific stem cell types and provides public access to Google’s online search information. [Read more…]
Breaking: Cynata Reports Extremely Positive Interim Data for MSC Product, CYP-001, in Model of GvHD
Australian stem cell company Cynata Therapeutics released news today than interim analysis clearly demonstrates efficacy of Cynata’s unique Cymerus™ mesenchymal stem cell (MSC) product, CYP-001, in a preclinical model of Graft-versus-Host disease (GvHD). This disease often follows a bone marrow transplant procedure and occurs when the immune cells in the donor material (the graft) attack the recipient’s tissues (the host) as “foreign”. Bone marrow transplants are used in the treatment of certain cancers, including leukaemia. [Read more…]
What Types of Mesenchymal Stem Cell (MSC) Research Are Getting Funded?
To analyze trends within the mesenchymal stem cell (MSC) industry, it is valuable to consider grant rate data. Previously, the U.S. federal government operated an online tool called CRISP (“Computer Retrieval of Information on Scientific Projects”). It was a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other U.S. research institutions. The database allowed users to search the CRISP interface for grants funding for specific types of scientific research, using text-based search terms.
However, that has since been replaced by RePORTer (Research Portfolio Online Reporting Tools)1, a more powerful database and search tool supported by the U.S. Department of Health and Human Services. RePORTer allows users to search a comprehensive repository of National Institutes of Health (NIH) funded research projects resulting from NIH funding. [Read more…]
Current Bottlenecks in MSC Research: Widespread MSC Misconceptions
This is a guest post from RoosterBio, written by Jon Rowley. RoosterBio is an innovative company that provides standardized stem cell product platforms to enable rapid clinical and commercial translation.
We blogged several months ago about bottlenecks in the bioprocessing of Mesenchymal Stem Cells that are impeding their clinical translation. While the development of robust and scalable manufacturing methods, reduced cost of goods, and implementation of solid Quality Systems are all necessary for increased clinical use of MSCs, there are also current misconceptions surrounding MSCs, rooted in decades-old science, that are holding the field back. [Read more…]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 12
- Next Page »